Patents Assigned to Calydon
  • Tissue-specific enhancer active in prostate
    Patent number: 5830686
    Abstract: The invention provides a human prostate-specific transcriptional regulatory sequence, polynucleotides comprising such regulatory regions, toxin gene constructs wherein a toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence, and methods for treating prostate disease using such toxin gene contructs.
    Type: Grant
    Filed: January 13, 1994
    Date of Patent: November 3, 1998
    Assignee: Calydon
    Inventor: Daniel R. Henderson